Patent details

EP2125894 Title: BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2125894
WO Application Number:
US2008003735
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08742182.2
WO Publication Number:
WO2008118356
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
21/03/2008
Grant date:
19/12/2018
EP Publication Date:
02/12/2009
WO Publication Date:
02/10/2008
Claims Translations Received Date:
Claims Translation B1 Received Date:
18/02/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
19/12/2018
EP B1 Publication Date:
19/12/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/03/2028
Lapsed By Expiration Date:
Patent Validated Date:
27/03/2019
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
18/02/2021
 
 

 

Name:
UCB Biopharma SRL
Address:
Allée de la Recherche 60, 1070, Brussels, Belgium (BE)

Historical Applicant/holder

From:
19/12/2018
To:
18/02/2021

 

Name:
UCB Biopharma SPRL
Address:
Allée de la Recherche, 60, 1070 Brussels, Belgium (BE)

From:
19/12/2018
To:
18/02/2021

 

Name:
Biogen MA Inc.
Address:
225 Binney Street, MA 02142, Cambridge, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
26/03/2019
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
BURKLY, Linda C.
Address:
West Newton, Massachusetts 02465, United States of America (US)

2

Name:
FERRANT-ORGETTAS, Janine L.
Address:
Gloucester, Massachusetts 01930, United States of America (US)

3

Name:
GARBER, Ellen A.
Address:
Cambridge, Massachusetts 02138, United States of America (US)

4

Name:
HSU, Yen-ming
Address:
Lexington, Massachusetts 02420, United States of America (US)

5

Name:
SU, Lihe
Address:
Reading, Massachusetts 01867, United States of America (US)

6

Name:
TAYLOR, Frederick R.
Address:
Milton, Massachusetts 02186, United States of America (US)

7

Name:
ADAMS, Ralph
Address:
Slough Berkshire SL1 3WE, United Kingdom (GB)

8

Name:
BROWN, Derek Thomas
Address:
Slough Berkshire SL1 3WE, United Kingdom (GB)

9

Name:
POPPLEWELL, Andrew George
Address:
Slough Berkshire SL1 3WE, United Kingdom (GB)

10

Name:
ROBINSON, Martyn Kim
Address:
Slough Berkshire SL1 3WE, United Kingdom (GB)

11

Name:
SHOCK, Anthony
Address:
Slough Berkshire SL1 3WE, United Kingdom (GB)

12

Name:
TYSON, Kerry Louise
Address:
Slough Berkshire SL1 3WE, United Kingdom (GB)

Priority

1

Priority Patent Number:
920495 P
Priority Date:
27/03/2007
Priority Country:
United States of America (US)

2

Priority Patent Number:
919938 P
Priority Date:
22/03/2007
Priority Country:
United States of America (US)

3

Priority Patent Number:
919816 P
Priority Date:
22/03/2007
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07K 16/28;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
09/21
Publication date:
03/03/2021
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
13/19
Publication date:
27/03/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
52/18
Publication date:
19/12/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201852
Publication date:
26/12/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201851
Publication date:
19/12/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC202100341A
Date Registered:
18/02/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
UCB Biopharma SRL
Address:
Allée de la Recherche 60, 1070, Brussels, Belgium (BE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/03/2026
Annual Fee Number:
19
Annual Fee Amount:
1300 Euro
Last Annual Payment Date:
17/02/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
1200 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
26/03/2019 Outgoing Correspondence Letter no formal defects 1 PDF /4/8/7/2/5/0800352784/docs/ep08742182.2_0_261642l271.pdf
18/02/2019 Claims First filed claims 4 PDF /4/8/7/2/5/0800352784/docs/ep08742182.2_1_claims20190218144601212.pdf